Eytan Aharon Ben-ami

Dr. Eytan Aharon Ben-Ami, MD

Senior Physician, Sarcoma & Bone Oncology Service – Sheba Medical Center

Leading Expert in Sarcoma, Bone Tumors & Innovative Cancer Therapies

Dr. Eytan Ben-Ami is a highly specialized medical oncologist with extensive experience in the treatment of sarcomas and complex bone tumors, including rare and aggressive cancers.

As a senior physician at Sheba Medical Center, he plays a key role in delivering multidisciplinary, highly personalized care, often collaborating with pediatric and adult oncology teams to manage challenging soft tissue and bone malignancies.

Areas of Expertise

• Sarcoma (Core Expertise)
  Soft tissue sarcomas, liposarcoma, leiomyosarcoma, and rare tumor subtypes
•  
• Bone Oncology
  Osteosarcoma and other primary bone tumors
•  
• Advanced Medical Oncology
  • Targeted therapies and immunotherapy
  •  
  • Personalized treatment protocols for rare cancers
  •  
• Early-Phase Clinical Trials (Phase I)
  Access to innovative and next-generation cancer treatments

Clinical Leadership & Innovation

Dr. Ben-Ami is at the forefront of oncology innovation at Sheba, contributing to:

• Leadership in early-phase (Phase I) clinical trials, offering patients access to cutting-edge therapies
• Development of new treatment approaches for rare cancers
• Implementation of patient-centered innovations, including novel care delivery models

He also founded Sheba’s Clinical Research Organization (CRO), a pioneering initiative supporting advanced clinical research across multiple disciplines.

International Training & Expertise

Dr. Ben-Ami completed a prestigious fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute / Harvard Cancer Center, one of the world’s leading cancer research institutions.

His approach combines:

• Global expertise in rare tumor management
• Advanced diagnostics and precision oncology
• Access to innovative therapies not widely available

Leadership & Academic Roles

• Senior Physician, Sarcoma & Bone Oncology Service, Sheba Medical Center
• Head of Oncology Division & Early-Phase Clinical Trials Unit
• Founder, Sheba Clinical Research Organization (CRO)
• Academic affiliation with Tel Aviv University

Research & Scientific Contribution

Dr. Ben-Ami is an active researcher with 40+ scientific publications, focusing on:

• Early detection and monitoring of sarcomas
• Molecular and viral mechanisms in rare tumors
• Development of innovative oncology treatments

He is also leading pilot programs in advanced immunotherapy delivery, improving accessibility and patient experience.

Clinical Approach

Dr. Ben-Ami is known for managing complex and rare cancer cases, offering:

• Highly individualized treatment strategies
• Multidisciplinary collaboration across oncology, surgery, and pediatrics
• Access to breakthrough therapies through clinical trials

Patient-Centered Care

Dr. Ben-Ami provides advanced, compassionate oncology care, combining cutting-edge science with a personalized approach, ensuring patients receive the most effective and innovative treatment options available.

A Leader in Rare Cancer Treatment

Through his expertise in sarcoma, bone oncology, and early-phase clinical research, Dr. Ben-Ami offers patients access to one of the most advanced programs globally for rare and complex cancers.